Inogen (INGN) Construction in Progress (2013 - 2022)
Inogen (INGN) reported Construction in Progress of $2.9 million for Q4 2022, up 78.77% year-over-year from $1.6 million in Q4 2021, and up 3.06% on a QoQ basis from $2.8 million in Q3 2022.
Inogen (INGN) has 10 years of Construction in Progress data on file, last reported at $2.9 million in Q4 2022.
- Quarterly Construction in Progress rose 78.77% year-over-year to $2.9 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $2.9 million (up 78.77% YoY) and the FY2022 annual result came in at $2.9 million, up 78.77% from the prior year.
- Construction in Progress advanced to $2.9 million in Q4 2022 per INGN's latest filing, from $2.8 million in the prior quarter.
- Across five years, Construction in Progress topped out at $3.7 million in Q3 2018 and bottomed at $1.5 million in Q3 2019.
- The 5-year median for Construction in Progress is $2.7 million (2022), against an average of $2.6 million.
- The widest annual swing landed in 2018, when Construction in Progress jumped 1281.13%; it then sank 60.08% in 2019.
- Tracing INGN's Construction in Progress over 5 years: stood at $3.1 million in 2018, then sank by 43.32% to $1.8 million in 2019, then surged by 32.21% to $2.3 million in 2020, then sank by 30.08% to $1.6 million in 2021, then jumped by 78.77% to $2.9 million in 2022.
- Per Business Quant, the three latest INGN Construction in Progress figures stand at $2.9 million (Q4 2022), $2.8 million (Q3 2022), and $2.9 million (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 509.50 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 2.84 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.83 Mn |
| Jun 30, 2021 | 3.51 Mn |
| Mar 31, 2021 | 3.37 Mn |
| Dec 31, 2020 | 2.34 Mn |
| Sep 30, 2020 | 1.57 Mn |
| Mar 31, 2020 | 2.44 Mn |
| Dec 31, 2019 | 1.77 Mn |
| Sep 30, 2019 | 1.46 Mn |
| Jun 30, 2019 | 2.62 Mn |
| Mar 31, 2019 | 3.43 Mn |
| Dec 31, 2018 | 3.13 Mn |
| Sep 30, 2018 | 3.66 Mn |
| Jun 30, 2018 | 3.07 Mn |
| Mar 31, 2018 | 1.93 Mn |
| Dec 31, 2017 | 408,000.00 |
| Sep 30, 2017 | 265,000.00 |
| Jun 30, 2017 | 230,000.00 |
| Mar 31, 2017 | 305,000.00 |
| Dec 31, 2016 | 75,000.00 |
| Sep 30, 2016 | 430,000.00 |
| Jun 30, 2016 | 478,000.00 |
| Mar 31, 2016 | 847,000.00 |
| Dec 31, 2015 | 578,000.00 |
| Sep 30, 2015 | 593,000.00 |
| Jun 30, 2015 | 400,000.00 |
| Mar 31, 2015 | 146,000.00 |
| Dec 31, 2014 | 193,000.00 |
| Sep 30, 2014 | 1.19 Mn |
| Jun 30, 2014 | 1.07 Mn |
| Mar 31, 2014 | 971,000.00 |
| Dec 31, 2013 | 1.09 Mn |